A new method of testing the most common cause of life-threatening infection in people with cystic fibrosis could improve efforts to study and combat the illness.
Mar 17, 2015
0
41
Preventing lung infections in childhood could stop later life-threatening infections for people with cystic fibrosis (CF), according to the latest research carried out at Aston University.
Mar 6, 2015
0
130
A treatment pioneered at the University of Pittsburgh Center for Vaccine Research (CVR) is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called "superbugs" ...
Dec 10, 2014
0
0
Bacterial infections can cause major problems for people undergoing treatment for cancer and other diseases. The concern is especially acute during hospitalization, when patients often have weakened immune function.
Oct 23, 2014
0
0
A team of five researchers and clinicians in Singapore led by Dr Desmond Heng, ICES, has developed a new combination of drugs to effectively combat bacteria in the lungs which lead to common respiratory system infections, ...
Sep 15, 2014
0
0
Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered the pattern of infection of the bacterium responsible for causing severe lung infections in people with cystic fibrosis.
Sep 2, 2014
0
0
(Medical Xpress)—A team of medical researchers from several institutions in the U.S. has found that some ionic liquids are able to safely penetrate both skin and bacterial biofilms, opening the door to a possible breakthrough ...
Scientists at Queen's University Belfast have made a breakthrough in the fight against the most resistant hospital superbugs.
Aug 19, 2014
0
0
A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio. Their investigation suggests that the particular genetic element ...
Aug 11, 2014
0
0
A rapid diagnostic test for multi-resistance to broad-spectrum antibiotics has just been developed at the University of Fribourg. Prof Patrice Nordmann and Dr Laurent Poirel of the Medical and Molecular Microbiology Unit ...
Jun 27, 2014
0
0
